Stocksigma LogoStocksigma Logo

Goldline Pharmaceutical Schedules Board Meeting to Approve Half-Year Results

Goldline Pharmaceutical Limited announced that its Board of Directors will meet on 14th Nov'26 to consider and approve the standalone unaudited financial

Goldline Pharmaceutical Schedules Board Meeting to Approve Half-Year Results

Goldline Pharmaceutical Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Goldline Pharmaceutical Schedules Board Meeting to Approve Half-Year Results Goldline Pharmaceutical Limited announced that its Board of Directors will meet on 14th Nov'26 to consider and approve the standalone unaudited financial results for the half-year ended 30th Sep'26, alongside the statement of assets and liabilities. The meeting outcome will be disclosed following the board's conclusion.

Original exchange filing (PDF)

More announcements from Goldline Pharmaceutical Ltd

All Goldline Pharmaceutical Ltd announcements